These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Norrin mediates tumor-promoting and -suppressive effects in glioblastoma via Notch and Wnt. El-Sehemy A; Selvadurai H; Ortin-Martinez A; Pokrajac N; Mamatjan Y; Tachibana N; Rowland K; Lee L; Park N; Aldape K; Dirks P; Wallace VA J Clin Invest; 2020 Jun; 130(6):3069-3086. PubMed ID: 32182224 [TBL] [Abstract][Full Text] [Related]
24. Protein O-fucosyltransferase 1 expression impacts myogenic C2C12 cell commitment via the Notch signaling pathway. Der Vartanian A; Audfray A; Al Jaam B; Janot M; Legardinier S; Maftah A; Germot A Mol Cell Biol; 2015 Jan; 35(2):391-405. PubMed ID: 25384974 [TBL] [Abstract][Full Text] [Related]
25. SKA3 promotes glioblastoma proliferation and invasion by enhancing the activation of Wnt/β-catenin signaling via modulation of the Akt/GSK-3β axis. Li C; Yang J; Lei S; Wang W Brain Res; 2021 Aug; 1765():147500. PubMed ID: 33895155 [TBL] [Abstract][Full Text] [Related]
26. O-fucosylation of the notch ligand mDLL1 by POFUT1 is dispensable for ligand function. Müller J; Rana NA; Serth K; Kakuda S; Haltiwanger RS; Gossler A PLoS One; 2014; 9(2):e88571. PubMed ID: 24533113 [TBL] [Abstract][Full Text] [Related]
27. Blockade of a Laminin-411-Notch Axis with CRISPR/Cas9 or a Nanobioconjugate Inhibits Glioblastoma Growth through Tumor-Microenvironment Cross-talk. Sun T; Patil R; Galstyan A; Klymyshyn D; Ding H; Chesnokova A; Cavenee WK; Furnari FB; Ljubimov VA; Shatalova ES; Wagner S; Li D; Mamelak AN; Bannykh SI; Patil CG; Rudnick JD; Hu J; Grodzinski ZB; Rekechenetskiy A; Falahatian V; Lyubimov AV; Chen YL; Leoh LS; Daniels-Wells TR; Penichet ML; Holler E; Ljubimov AV; Black KL; Ljubimova JY Cancer Res; 2019 Mar; 79(6):1239-1251. PubMed ID: 30659021 [TBL] [Abstract][Full Text] [Related]
28. Endothelial cells create a stem cell niche in glioblastoma by providing NOTCH ligands that nurture self-renewal of cancer stem-like cells. Zhu TS; Costello MA; Talsma CE; Flack CG; Crowley JG; Hamm LL; He X; Hervey-Jumper SL; Heth JA; Muraszko KM; DiMeco F; Vescovi AL; Fan X Cancer Res; 2011 Sep; 71(18):6061-72. PubMed ID: 21788346 [TBL] [Abstract][Full Text] [Related]
29. MicroRNA-598 Inhibits Cell Proliferation and Invasion of Glioblastoma by Directly Targeting Metastasis Associated in Colon Cancer-1 (MACC1). Wang N; Zhang Y; Liang H Oncol Res; 2018 Sep; 26(8):1275-1283. PubMed ID: 29444745 [TBL] [Abstract][Full Text] [Related]
30. Role of glycosyltransferase PomGnT1 in glioblastoma progression. Lan J; Guo P; Lin Y; Mao Q; Guo L; Ge J; Li X; Jiang J; Lin X; Qiu Y Neuro Oncol; 2015 Feb; 17(2):211-22. PubMed ID: 25085363 [TBL] [Abstract][Full Text] [Related]
31. JAK2/STAT3 targeted therapy suppresses tumor invasion via disruption of the EGFRvIII/JAK2/STAT3 axis and associated focal adhesion in EGFRvIII-expressing glioblastoma. Zheng Q; Han L; Dong Y; Tian J; Huang W; Liu Z; Jia X; Jiang T; Zhang J; Li X; Kang C; Ren H Neuro Oncol; 2014 Sep; 16(9):1229-43. PubMed ID: 24861878 [TBL] [Abstract][Full Text] [Related]
32. ZWINT: A potential therapeutic biomarker in patients with glioblastoma correlates with cell proliferation and invasion. Yang L; Han N; Zhang X; Zhou Y; Chen R; Zhang M Oncol Rep; 2020 Jun; 43(6):1831-1844. PubMed ID: 32323832 [TBL] [Abstract][Full Text] [Related]
33. POFUT1 promotes colorectal cancer development through the activation of Notch1 signaling. Du Y; Li D; Li N; Su C; Yang C; Lin C; Chen M; Wu R; Li X; Hu G Cell Death Dis; 2018 Sep; 9(10):995. PubMed ID: 30250219 [TBL] [Abstract][Full Text] [Related]
34. Non-coding RNAs as Key Regulators of the Notch Signaling Pathway in Glioblastoma: Diagnostic, Prognostic, and Therapeutic Targets. Shahcheraghi SH; Asl ER; Lotfi M; Ayatollahi J; Khaleghinejad SH; Aljabali AAA; Bakshi HA; El-Tanani M; Charbe NB; Serrano-Aroca Á; Mishra V; Mishra Y; Goyal R; Hromić-Jahjefendić A; Uversky VN; Lotfi M; Tambuwala MM CNS Neurol Disord Drug Targets; 2024; 23(10):1203-1216. PubMed ID: 38279763 [TBL] [Abstract][Full Text] [Related]
35. Pofut1 point-mutations that disrupt O-fucosyltransferase activity destabilize the protein and abolish Notch1 signaling during mouse somitogenesis. Ajima R; Suzuki E; Saga Y PLoS One; 2017; 12(11):e0187248. PubMed ID: 29095923 [TBL] [Abstract][Full Text] [Related]
36. The lncRNA RP3-439F8.1 promotes GBM cell proliferation and progression by sponging miR-139-5p to upregulate NR5A2. Qi J; Pan L; Yu Z; Ni W Pathol Res Pract; 2021 Jul; 223():153319. PubMed ID: 33991848 [TBL] [Abstract][Full Text] [Related]
37. Lemur tyrosine kinase 2 has a tumor-inhibition function in human glioblastoma by regulating the RUNX3/Notch pathway. Zhang L; Luo P; Mao X; Sun J; Wei J; Yang Y; Zhang Y; Jiang X Biochim Biophys Acta Mol Cell Res; 2023 Oct; 1870(7):119509. PubMed ID: 37271222 [TBL] [Abstract][Full Text] [Related]
38. Structure of human POFUT1, its requirement in ligand-independent oncogenic Notch signaling, and functional effects of Dowling-Degos mutations. McMillan BJ; Zimmerman B; Egan ED; Lofgren M; Xu X; Hesser A; Blacklow SC Glycobiology; 2017 Aug; 27(8):777-786. PubMed ID: 28334865 [TBL] [Abstract][Full Text] [Related]
39. miR-181d/MALT1 regulatory axis attenuates mesenchymal phenotype through NF-κB pathways in glioblastoma. Yang F; Liu X; Liu Y; Liu Y; Zhang C; Wang Z; Jiang T; Wang Y Cancer Lett; 2017 Jun; 396():1-9. PubMed ID: 28286260 [TBL] [Abstract][Full Text] [Related]
40. Upregulation of ASCL1 and inhibition of Notch signaling pathway characterize progressive astrocytoma. Somasundaram K; Reddy SP; Vinnakota K; Britto R; Subbarayan M; Nambiar S; Hebbar A; Samuel C; Shetty M; Sreepathi HK; Santosh V; Hegde AS; Hegde S; Kondaiah P; Rao MR Oncogene; 2005 Oct; 24(47):7073-83. PubMed ID: 16103883 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]